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Abstract
Prtority setting 0f health interventi0ns is 0ften ad-h0c and res0urces are n0t used t0 an 0ptimal 
extent. Underlying pr0blem is that multiple criteria play a role and decisi0ns are c0mplex. 
Interventi0ns may be ch0sen t0 maximize general p0pulati0n health, t0 reduce health inequalities 
0f disadvantaged 0 r vulnerable gr0 ups, ad/0 r t0  resp0 nd t0  life-threatening situati0 ns, all with 
respect to practical and budgetary c0nstraints. This is the type 0f problem that p0licy makers are 
typically bad at s0lving rati0nally, unaided. They tend to use heuristic 0 r intuitive approaches to 
simplify romplexity, and in the process, imp0rtant inf0rmati0n is ign0red. Next, p0licy makers may 
select interventi0ns for 0nly p0litical m0tives.
This indicates the need for rati0nal and transparent approaches to pri0rity setting. Over the past 
decades, a number 0f approaches have been devefoped, including evidence-based medicine, burden 
0f disease analyses, c0st-effectiveness analyses, and equity analyses. H0wever, these approaches 
c0ncentrate 0n single criteria 0nly, whereas in reality, p0licy makers need t0 make ch0ices taking 
int0 acc0unt multiple criteria simultane0usly. M0re0ver, they d0 n0t c0ver all criteria that are 
relevant to p0licy makers.
Therefore, the devefopment 0f a multi-criteria approach to pri0rity setting is necessary, and this 
has indeed recently been identified as 0ne 0f the m0st imp0rtant issues in health system research. 
In 0ther scientific disciplines, multi-criteria decisi0n analysis is well devel0ped, has gained 
widespread acceptance and is routinely used. This paper presents the main principles 0f multi­
criteria decisi0n analysis. There are 0nly a very few applicati0ns to guide res0urce all0cati0n 
decisi0ns in health. W e call for a shift away from present pri0rity setting t00ls in health -  that tend 
to focus 0n single criteria -  towards transparent and systematic approaches that take into acc0unt 
all relevant criteria simultane0usly.
Background
Pertaining health needs and accelerating technological 
development put an ever-increasing demand on limited 
health budgets. Policy makers need to make important
decisions on the use of public funds -  to target which dis­
ease areas, which populations, and with which interven­
tions. However, these choices may not be based on a 
rational and transparent process, and resources may not
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be used to an optimal extent [1,2]. For example, despite 
evidence that investing in primary health care is more 
effective than investing in specialized health care, alloca­
tions to primary care in Ghana have remained behind 
those allocated to tertiary care [3]. The underlying prob­
lem is that decisions on the choice of health interventions 
are complex and multifaceted [4,5], and the process is 
therefore ad-hoc or history-based [1,2]. Many criteria, or 
factors, play a role, and present the type of problem that 
behavioral decision research shows policy makers are typ­
ically quite bad at solving, unaided [6,7] (Figure 1).
A first, and probably most important, criterion is the soci­
etal wish to maximize general population health. This has 
indeed been the basis of many national disease programs 
in the past century [8]. A second set of criteria relates to 
the distribution o f health in the population. Societies may 
give high priority to interventions that target vulnerable 
population groups such as the poor [9,10], the severely ill 
[11], or children or women of reproductive age [12], 
because they are more deserving of health care than others 
[13,14]. Also, societies may give high priority to the eco­
nomically productive people to stimulate economic 
growth [15], or low priority to people who require health 
care as a result from irresponsible behavior (e.g. smoking) 
[16]. A third set of criteria responds to specific societal pref-
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erences, e.g. for acute care in life threatening situations, or 
for curative over preventive services [17].
A fourth set of criteria relates to the budgetary and practical 
constraints that policy makers face when implementing 
interventions, including costs and availability of trained 
health workers [18], and may take these into account 
when choosing between interventions. Fifthly, political 
criteria may play an important role. Policy makers may 
not always be benevolent maximizers of social welfare, 
but may also act out of own (political) self-interest [19]. 
Interests groups in societies exercise their influence on 
policy makers to prioritise interventions according to their 
objectives, and policy makers may be sensitive to this in 
their efforts to maximize political support. For example, 
health expenditures in many developing countries are 
often focused on services for richer areas or groups at the 
expense of the poor, even where the latter offers greater 
scope for cost-effective healthcare [19]. Also, policy mak­
ers may follow funding preferences of (international) 
organisations, which may not always cohere with national 
priorities [20-22]. The above list may not be exhaustive, 
and still other criteria may be important.
When confronted with such complex problems, policy­
makers tend to use intuitive or heuristic approaches to
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Figure 1
Ad hoc priority setting and rational priority setting.
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simplify complexity, and in the process, important infor­
mation may be lost, and priority setting is ad-hoc. Or 
worse, they act out of political self-interest and prioritize 
interventions according to their own objectives. In other 
words, policy makers may not always well placed to make 
informed well-thought choices involving trade-offs of 
societal values [6,7].
The above indicates the need for a rational and transpar­
ent approach to priority setting that guides policy makers 
in their choice of health interventions, and that maxi­
mizes social welfare. This paper presents an overview of 
the approaches that have been developed over the past 
decades, and argues that these offer little guidance to pol­
icy makers. They concentrate on single criteria only, 
whereas in reality, policy makers need to make choices 
taking into account multiple criteria simultaneously. 
Moreover, they do not cover all criteria that are relevant to 
policy makers. In other disciplines, multi-criteria decision 
analysis (MCDA) is routinely used in similar problems, 
and we show its basic concepts and most important meth­
ods. We call for the application of MCDA in health, and 
present some first examples.
Rational approaches to  prio rity  setting
The past decades have witnessed the development of 
number of rational and transparent approaches to priority 
setting. Most prominent has been the development of evi­
dence-based medicine, or the use of interventions with 
established effectiveness. This dates back to the beginning 
of the last century but was institutionalized by the foun­
dation of the Cochrane Collaboration in 1993 [23-25]. 
The Cochrane Collaboration produces and disseminates 
systematic reviews of healthcare interventions and pro­
motes the search for evidence in the form of clinical trials 
and other studies of interventions.
Because of steep increases in health interventions costs in 
western countries in the 1980's, economists proposed the 
use of cost-effectiveness analysis of health interventions. The 
underlying notion is that interventions should not only 
have established effectiveness, but should also be worth 
its costs [26]. For a certain budget, population health 
would then maximized by choosing interventions that 
show best value for money ('most cost-effective'). The 
World Bank promoted the concept in developing coun­
tries in 1993 [27] and recently the World Health Organi­
zation have made such information available at the 
regional level through the WHO-CHOICE project, e.g. on 
tuberculosis and HIV/AIDS control [28-30]. Work is 
underway to apply these cost-effectiveness estimates to 
the country level [31].
Also in the early 1990's, the World Bank expanded epide­
miological mortality measures to the concept of burden o f
disease analysis [32]. Burden of disease analysis measures 
ill health in terms of morbidity and mortality to indicate 
the most important disease areas in a country. Its propo­
nents consider the analysis as an important aid to priority 
setting as it would guide policy makers in targeting their 
intervention at the most important disease areas. Others 
argue that it lacks a conceptual basis for priority setting of 
health interventions, as the size of a disease problem has 
no relation to the potential for effective reduction [33]. 
Nevertheless, burden of disease analysis has been applied 
in many developed and developing countries including 
Eritrea, Kenya, Ethiopia, Uganda, and Tanzania in East 
Africa, Algeria, Morocco and Tunis in Northern Africa, and 
India [34,35].
With advances in population health in developing coun­
tries in the past decades, policy makers have increasingly 
become aware of disparities in health status between dif­
ferent groups in society. The past few years has witnessed 
an increased attention for equity analyses describing the 
distributional impact of interventions [9-12]. These stud­
ies aim to analyze to the extent interventions reach and 
benefit disadvantages groups, such as the poor or certain 
ethnicities, or otherwise vulnerable populations.
The need for m ulti-criteria  decision analysis
However, the above approaches offer limited guidance to 
policy makers in their choice of interventions, for a 
number of reasons. Firstly, they were developed in isola­
tion from each other, and concentrate on single criteria for 
priority setting -  be it effectiveness, cost-effectiveness, bur­
den of disease, or equity analysis, and do not advice on 
how to integrate or judge the relative importance of each 
criterion. In reality, policy makers need to make choices 
on interventions taking those criteria into account simul­
taneously. Moreover, criteria can easily conflict. For exam­
ple, interventions targeting marginalized populations in 
remote areas of a country are likely to be more costly and 
therefore less cost-effective than those covering only peo­
ple in urban areas [36]. Also, not all criteria are equally 
important: depending on the pro-poor stance of a coun­
try, policy makers may value interventions that target the 
poor more highly than those that stimulate economic 
growth.
Secondly, these approaches do not cover all criteria that 
are relevant to policy makers. For example, they are not 
able to capture preferences of society regarding 'the rule of 
rescue' in acute cure or regarding interventions related to 
irresponsible behavior of patients. A further complicating 
factor is that prioritisation decisions typically draw upon 
multidisciplinary knowledge bases, incorporating clinical 
medicine, public health, social sciences and ethics, and 
policy makers lack expertise to adequately interpret on all 
these aspects.
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As a result, policy makers may not be able to utilize all 
available and necessary information in choosing between 
different interventions, and priority setting is ad-hoc (Fig­
ure 1). This stresses the need for the scientific develop­
ment of MCDA to support priority setting, which has 
recently indeed been identified as one of the most impor­
tant issues in health system research [5]. Baltussen and 
others have argued that MCDA should allow a trade-off 
between various criteria, and should establish the relative 
importance of criteria in a way that allows a rank ordering 
of a comprehensive set of interventions [4,37] (Figure 1). 
The underlying idea is that policy makers fund interven­
tions according to this rank ordering until their budget is 
exhausted.
Methods of m u lti-criteria  decision analysis
In stark contrast with the near-absence of applications of 
MCDA to allocation decisions in health care is the wide­
spread acceptance and routine use of MCDA in other dis­
ciplines, e.g. to structure remedial decisions at 
contaminated sites in environmental sciences [38]. 
MCDA has also been applied in agricultural [39], energy 
[40], and marketing [41] sciences. In those disciplines, 
MCDA has evolved as a response to the observed inability 
of people to effectively analyze multiple streams of dis­
similar information. The analysis establishes preferences 
between options by reference to an explicit set of objec­
tives that the decision making body has identified, and for 
which it has established measurable criteria to assess the 
extent to which the objectives have been achieved [42]. 
MCDA offers a number of ways of aggregating the data on 
individual criteria to provide indicators of the overall per­
formance of options.
This section outlines the main principles of MCDA, heav­
ily drawing on standard works in those disciplines [42­
45]. Wherever we use to term 'option' in this paper, this 
refers to 'intervention' in the context of priority setting in 
health, and the terms are used interchangeably. It first 
presents the performance matrix, which is a standard fea­
ture of every multi-criteria analysis. Next, it explains how 
the basic information in the performance matrix can be 
processed -  either qualitatively or quantitatively.
The perform ance m atrix
In a performance matrix, each row describes an option 
and each column describes the performance of the 
options against each criterion. The criteria are the meas­
ures of performance by which the options will be judged, 
and must be carefully selected, to assure completeness, 
feasibility, and mutual independence, and avoid redun­
dancy and an excessive number of criteria. The individual 
performance assessments are often qualitative descrip­
tions, or natural units, or sometimes a (crude) numerical 
scale [42]. Table 1 shows a simplified example, on the 
basis of the performance of a number of different inter­
ventions in regard to a set of criteria thought to be relevant 
in policy making. These criteria are cost-effectiveness, 
severity of disease, whether a disease is more among the 
poor, and age. As can be seen, some of these criteria are 
measured on a binary scale (a tick indicates a disease is 
more prevalent among the poor than among the rich), 
nominal scale (age), ordinal scales (severity of disease), or 
ratio scale (cost-effectiveness).
Q ualitative  analysis o f  the perform ance m atrix
The performance matrix may be the final product of the 
analysis, allowing the decision maker to qualitatively rank 
the options. Such intuitive processing of the data can be 
quick and effective, but it may also lead to the use of 
unjustified assumptions, causing incorrect ranking of 
options [42]. The decision maker can come to a few types 
of comparisons.
Dominance
Direct inspection of the performance matrix can show if 
any of the options are dominated by others. Dominance 
occurs when one option performs at least as well as 
another on all criteria and strictly better than the other on 
at least one criterion. In practice, dominance is likely to be 
rare, and the extent to which it can help to discriminate 
between many options and to support real decisions is 
correspondingly limited.
Subjective interpretation
Decision makers may also use the performance matrix to 
add recorded performance levels across the rows 
(options) to make some holistic judgment between 
options about which ones are better. However, this
Tab le  1: P erform ance m a tr ix
Options Cost-effectiveness Severity of disease Disease of the poor Age
Antiretroviral treatment in HIV/AIDS US$200 per DALY •  • • • V 15 years and older
Treatment of childhood pneumonia US$20 per DALY •  • • • V 0 -14  years
Inpatient care for acute schizophrenia US$2000 per DALY •  • 15 years and older
Plastering for simple fractures US$50 per DALY • all
A  tick indicates the presence of a feature. Severity of disease is shown of a four-star scale, with more stars indicating a more severe disease.
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implies that all criteria contribute with equal importance 
to options' overall performance, when this has not been 
established. More generally, a subjective interpretation of 
the matrix is prone to many well-documented distortions 
of human judgments [6,7]. In marketing, this method is 
also called the 'pros and cons' or 'balance sheet' analysis, 
and is used by salespeople to gain commitment from a 
buyer by asking to think of the pros and cons of various 
alternatives [41].
Q uantitative  analysis o f  the perform ance m atrix
In analytically more sophisticated MCDA techniques the 
information in the basic matrix is usually converted into 
consistent numerical values. The key idea is to construct 
scales representing preferences for the consequences, to 
weight the scales for their relative importance, and then to 
calculate weighted averages across the preference scales 
[42].
First, the expected consequences of each option are 
assigned a numerical score reflecting the strength of pref­
erence scale for each option for each criterion. More pre­
ferred options score higher on the scale, and less preferred 
options score lower. The scoring can be based on a value 
function, which translates a measure of achievement on 
the criterion in to a value score on the scale. Alternatively, 
when a commonly agreed scale of measurement does not 
exist, direct rating can be used and is based on the judg­
ment of an expert simply to associate a number on that 
scale with the value of each option on that criterion. Or, 
scores can be obtained by eliciting from the decision 
maker a series of verbal pair wise assessments expressing a 
judgment of the performance of each option relative to 
each of the others (e.g. the Analytical Hierarchy Process 
does this (see below)). The scores are presented in Table 2 
in normal figure.
Second, numerical weights are assigned to define, for each 
criterion, the relative valuations of a shift between the top 
and bottom of the chosen scale. Weights can be obtained
Tab le  2: Scoring th e  options.
by comparing weights of criterions to the most important 
criterion, e.g. on the basis of group discussions. In a next 
step, those weights are calculated to sum up to 100 in 
total. In the example in Table 2, weights are presented in 
bold figure: 'cost-effectiveness' and 'disease of the poor' 
are both assigned a value of 40, and the other criteria a 
value of 10.
Mathematical routines then combine these two compo­
nents to give an overall assessment of each option being 
appraised. At this stage, it is important to determine 
whether trade-offs between different criteria are accepta­
ble, so that good performance on one criterion can in 
principle compensate for weaker performance on another. 
Most public decisions admit such trade-offs, but there 
may be some circumstances, perhaps where ethical issues 
are central, where trade-offs of this type are not accepta­
ble. If it is not acceptable to consider trade-offs between 
criteria, then there are a limited number of noncom pen­
satory MCA techniques available [42]. Where compensa­
tion is acceptable, and low scores on one criterion may be 
compensated by high scores on another, compensatory 
MCA techniques are used that involve aggregation of each 
option's performance across all the criteria to form an 
overall assessment of each option, on the basis of which 
the set of options can be compared. These techniques are 
usually based on multi-attribute utility theory [46]. The 
principal difference between the main families of MCA 
methods is the way in which this aggregation is done.
The simple linear additive evaluation model 
If it can either be proved, or reasonably assumed, that the 
criteria are preferentially independent of each other, then 
the simple linear additive evaluation model is applicable. 
The linear model shows how an option's values on the 
many criteria can be combined into one overall value. 
This is done through multiplication of the value score on 
each criterion by the weight of that criterion, and then 
adding all those weighted scores together. For example, in 
Table 2, antiretroviral treatment in HIV/AIDS scores 50 on
Options Cost-effectiveness Severity of disease Disease of the poor Age T o ta l
Antiretroviral treatment in HIV/AIDS 50 100 100 0 70
Treatment of childhood pneumonia 100 100 100 100 100
Inpatient care for acute schizophrenia 0 50 0 0 5
Plastering for simple fractures 100 25 0 50 48
W e ig h ts 40 10 40 10
Preference scores for 'cost-effectiveness' are obviously inverse to  its values, and are based on three categories: it scores 0 if the cost-effectiveness 
is higher than US$300 per DALY, 50 if between US$100 and US$300, and 100 if below US$ 100 per DALY. For 'disease of the poor', if the feature 
is present, it scores 100, otherwise 0. Preference scores for 'severity of disease' are scaled between 0 and 100 in proportion to  their stars. 
Assuming decision makers have a preference to  treat young people over old, '0-14 years' receives a score of 100, '15 years and older' a score of 0, 
and 'all ages' a score of 50. Preference scores are presented here for illustrative purposes only, and are arbitrary.
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the criterion 'cost-effectiveness', and the weight of that cri­
terion is 40/100: the weighted score is then 50 * 40/100 = 
20. In a similar way, the weighted scores on 'severity of 
disease', 'disease of the poor', and 'age' are respectively 10, 
40, and 0. The weighted scores sum up to 70, which is 
shown in the final column. Treatment of childhood pneu­
monia has a total score of 100, and is therefore the pre­
ferred option, followed by antiretroviral treatment in 
HIV/AIDS, plastering for simple fractures (48), and inpa­
tient care for acute schizophrenia (5).
The analytical hierarchy process
The analytic hierarchy process also develops a linear addi­
tive model, but, in its standard format, uses procedures for 
deriving the weights and the scores achieved by alterna­
tives, which are based, respectively, on pair wise compari­
sons between criteria and between options. Thus, for 
example, in assessing weights, the decision maker is asked 
a series of questions, each of which asks how important 
one particular criterion is relative to another for the deci­
sion being addressed.
Outranking methods
A rather different approach depends upon the concept of 
outranking, and seeks to eliminate alternatives that are, in 
a particular sense, 'dominated'. However, unlike the 
straightforward dominance idea outlined above, 'out­
ranked dominance' gives more influence to some criteria 
than others. One option is said to outrank another if it 
outperforms the other on enough criteria of sufficient 
importance (as reflected by the sum of the criteria 
weights) and is not outperformed by the other option in 
the sense of recording a significantly inferior performance 
on any one criterion. The outranking concept indirectly 
captures some of the political realities of decision-making, 
by downgrading options that perform badly on any one 
criterion (which might in turn activate strong lobbying 
from concerned parties and difficulty in implementing 
the option in question). In the example, in Table 1, all 
interventions are outranked by 'treatment of child pneu­
monia', and this illustrates its low discriminative power 
and hence its limited potential for priority setting, espe­
cially in the context of many criteria and many interven­
tions.
Applications to  health care
To date, MCDA knows very few applications to guide 
resource allocation decisions in health care, in either west­
ern or developing countries. These applications have used 
MCDA to different extents: to only illustrate its principles, 
to identify the criteria for priority setting, to identify and 
weigh the criteria for priority setting, or more comprehen­
sive approaches that result in a rank ordering of interven­
tions.
James et al. [47] illustrated the principles o f M C D A  by dem­
onstrating the potential impact of alternative weights for 
equity and efficiency criteria on the ranking of a number 
of hypothetical interventions.
The criteria for priority setting were identified by two 
merely qualitative studies in Uganda [4,48], including 
medical (e.g. effectiveness, cost-effectiveness, quality of 
evidence, severity of disease) and non-medical criteria 
(e.g. age, gender, and area of residence). Yet, they did not 
establish the weights of these criteria in a way that allows 
a rank ordering of interventions. Recently, a number of 
tools have been developed that take into account various 
criteria, but these do not explicitly attach weights to these 
criteria. Tugwell et al. [49 ] have proposed the 'equity effec­
tiveness loop' to highlight equity issues inherent in assess­
ing health needs, effectiveness and cost-effectiveness of 
interventions. The 'marginal budgeting for bottlenecks' 
tool aims to bridge between costing, cost-effectiveness 
and burden of disease analysis [50]. 'District health 
accounts' is a tool designed to help districts analyze their 
budgets and expenditures so that budgets can be set 
against priorities as defined by the prevailing burden of 
disease, and as such integrates budgeting, costing and bur­
den of disease analysis [51]. In the Netherlands, Dunning 
identified a number of criteria for public reimbursement 
of health care. However, some of its criteria -  especially 
medical need -  were not well defined, and its application 
therefore suboptimal [52].
Further studies have quantified the scores and weights o f cri­
teria, but these are typically limited to two criteria only: 
e.g. on cost-effectiveness and equity [53], or on age and 
severity of illness [54,55].
Recently, two comprehensive MCDA approaches have 
been developed. Wilson et al. [56] developed a prioritiza­
tion framework in an English Primary Care Trust. Through 
group discussion with policy makers, a number of criteria 
were identified (such as effectiveness, quality of life, 
access/equity, need, and prevention) and were weighed 
into four broad 'levels of importance'. Next, the groups 
scored four hypothetical interventions on those criteria on 
a scale from 0-10. A simple linear additive evaluation 
model was used to calculate overall scores, and interven­
tions were rank ordered according to their 'cost-value' 
ratio (estimated by dividing the costs of an interventions 
by the overall score). The authors consider the framework 
as a promising tool for prioritizing interventions in the 
Primary Care Trust.
Baltussen et al. carried out explorative research to priori­
tize health interventions in Ghana and Nepal using dis­
crete choice experiments [37,57]. In Ghana, criteria were 
identified through a series of group discussions with pol­
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icy makers, and included 'cost-effectiveness', 'poverty 
reduction', 'age', 'severity of illness', 'budget impact' and 
'burden of disease'. Intervention scores on those criteria 
were based on poverty profiles, burden of disease and 
cost-effectiveness analysis as presented in the World 
Health Report 2002 [58], and were expressed on a binary 
scale with arbitrary cut-off values. The relative weights of 
the various criteria were estimated through the use of dis­
crete choice experiments (DCE) [59], with a large number 
of policy makers. In the DCE, respondents choose their 
preferred option from sets of hypothetical interventions, 
each consisting of a bundle of criteria that described the 
intervention in question, with each criterion varying over 
a range of scores (Figure 2). The criteria were constant in 
each scenario, but the scores that described each criterion 
varied across interventions. Analysis of the options cho­
sen by respondents in each set revealed the extent to 
which each criterion was important. The work in Ghana 
showed that policy makers give high value to interven­
tions that are cost-effective (score of 1.42), reduce poverty 
(1.25), target the young (0.84), or target severe diseases 
(0.38). Using a simple linear additive evaluation model, 
total scores were calculated for a set of interventions, and 
rank ordered accordingly: high priority interventions in 
Ghana were prevention of mother to child transmission 
in HIV/AIDS control, and treatment of pneumonia and 
diarrhea in childhood. Lower priority interventions were 
certain interventions to control blood pressure, tobacco 
and alcohol abuse. Full details are reported elsewhere 
[37].
Conclusion
This paper has shown the basic principles of MCDA, and 
the need for its application in health. Whereas decisions 
in health care are often characterized by informal judg­
ment unsupported by analysis, MCDA may be an impor­
tant tool towards a more rational priority setting process.
This paper has introduced various approaches to MCDA, 
and these are mainly characterized by how the perform­
ance matrix is interpreted. Some approaches seem more 
useful to prioritise health interventions than others. First, 
the priority setting process involves many criteria and 
many interventions, and since intuitive processing of this 
complex data can lead to unjustified conclusions, quanti­
tative rather than qualitative analyses seem apt. Second, 
compensatory rather than non-compensatory techniques 
seem apt as public decisions typically allow trade-offs 
between criteria (perhaps except in situations where ethi­
cal issues are central). Third, because of the need to rank 
order a large number of interventions rather than to iden­
tify a single (or small number of) dominant interventions, 
the linear additive model seems more suitable than the 
outranking method. As noted above, first experiments 
with the linear additive model have been carried out in 
Ghana and Nepal [37,55], and encouraging results indi­
cate the potential of the approach to inform policy makers 
on actual priority setting of interventions.
This paper has illustrated the use of MCDA with some 
simplified examples. In a practical application, interven­
tions may be need evaluated at different geographic cov­
erage levels, to inform decisions on the choice between 
scaling up existing interventions, or implementing new 
interventions. WHO-CHOICE does evaluate interven­
tions at coverage levels of 50%, 80%, and 95% for this 
purpose [60,61]. In addition, interventions may need to 
be evaluated not only in isolation, but also in combina­
tion, since interactions may exist between interventions in 
either costs and/or effects. For this reason, WHO-CHOICE
Criteria Hypothetical interventions A B
Severity of disease
Number of potential beneficiaries
Age of target group
Individual health benefits
Poverty reduction
Cost-effectiveness
severe 
small 
young 
small 
neutral 
not cost-effective
not severe 
large 
elderly 
large 
positive 
cost-effective
Which one would you choose? 
Please tick a box
Figure2
Example of a question in a discrete choice experiment.
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does evaluate interventions in isolation and in combina­
tion [62].
The priority setting process should be strongly embedded 
in the organizational context, probably with a central role 
for an advisory panel [63]. An advisory panel comprises 
key stakeholders such as health personnel, policy makers, 
finance and information staff, and community represent­
atives. The panel has an important role in the definition 
of the relevant criteria and their relative importance for 
priority setting, and making recommendations for reallo­
cating resources on the basis of MCDA results. In the lat­
ter, the advisory panel may diverge from MCDA results 
because of e.g. pragmatic considerations. In other words, 
while MCDA suggests a rank ordering of interventions, 
this not necessarily means that interventions should be 
funded accordingly till the budget is exhausted. This is 
based on the notion that MCDA should not be seen as a 
formulaic or technocratic approach to priority setting, but 
rather as an aid to policy making.
MCDA will contribute to the fairness of the priority setting 
process. According to Daniels and Sabin's ethical frame­
work of accountability for reasonableness, priority setting 
is said to be fair if the priority setting process, decisions 
and rationales are accessible and relevant; and an appeals 
and enforcement mechanism are established [64]. MCDA 
contributes to the first two conditions because of its sys­
tematic and transparent nature.
We call for a shift away from present tools for priority set­
ting -  that tend to focus on single criteria for priority set­
ting -  towards transparent and systematic approaches that 
take into account all relevant criteria simultaneously. 
Although very little work has been done so far on compre­
hensive MCDA approaches, a number of tools that aim to 
bridge the different analytical approaches are being devel­
oped. It is time to assess the current state of the art of the 
methods, and to stimulate the development of a new gen­
eration of more evidence-based priority setting tools.
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